LataMed AI Trading Resumes on OTC Markets After Suspension
LataMed AI Corp., an artificial intelligence company, has resumed trading on OTC Markets under its symbol LMED. This move comes after a period of suspension. The trading activity is facilitated by Bitget, which has enabled the resumption of market operations.
The news was announced via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission, on August 11, 2026. LataMed AI Corp. is solely responsible for the information contained in the announcement.
No further details or statements were provided regarding the resumption of trading or its implications for investors.